KCM
WVE icon

Kynam Capital Management’s Wave Life Sciences WVE Stock Holding History

Kynam Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-965,193
Closed -$7M – 41
2026
Q1 		$7M Sell
965,193
-1,203,912
-56% -$15.7M 0.43% 30
2025
Q4 		$36.9M Sell
2,169,105
-2,390,948
-52% -$24.3M 2.36% 13
2025
Q3 		$33.4M Hold
4,560,053
– – 2.49% 13
2025
Q2 		$29.6M Sell
4,560,053
-339,444
-7% -$2.24M 3.19% 11
2025
Q1 		$39.6M Hold
4,899,497
– – 3.33% 12
2024
Q4 		$60.6M Hold
4,899,497
– – 3.58% 12
2024
Q3 		$40.2M Buy
4,899,497
+923,976
+23% +$5.52M 3.08% 11
2024
Q2 		$19.8M Buy
3,975,521
+43,439
+1% +$248K 1.53% 15
2024
Q1 		$24.3M Hold
3,932,082
– – 2.54% 13
2023
Q4 		$19.9M Hold
3,932,082
– – 2.2% 14
2023
Q3 		$22.6M Buy
3,932,082
+7,480
+0.2% +$34.1K 3.7% 8
2023
Q2 		$14.3M Buy
3,924,602
+116,726
+3% +$471K 1.96% 14
2023
Q1 		$16.5M Buy
3,807,876
+2,569,694
+208% +$11.8M 2.13% 15
2022
Q4 		$8.67M Sell
1,238,182
-159,297
-11% -$734K 1.33% 17
2022
Q3 		$5.04M Sell
1,397,479
-299,256
-18% -$991K 1.06% 20
2022
Q2 		$5.51M Sell
1,696,735
-214,993
-11% -$414K 1.41% 17
2022
Q1 		$3.82M Buy
1,911,728
+417,134
+28% +$1.02M 1.24% 18
2021
Q4 		$4.69M Buy
+1,494,594
New +$6.21M 2.51% 15

Other funds holding WVE

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Readystate Asset Management
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Kynam Capital Management's WVE Position: Q2 2026 in Review

Kynam Capital Management sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 965,193 shares — an estimated $7M sold.

Kynam Capital Management first reported a position in WVE in Q4 2021 and held it in 18 quarters. The position peaked at $60.6M in Q4 2024. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Kynam Capital Management reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Kynam Capital Management sold 965,193 Wave Life Sciences shares in Q2 2026, an estimated $7M.
  • Kynam Capital Management first reported a position in Wave Life Sciences in Q4 2021 and held it in 18 quarters.
  • Kynam Capital Management's Wave Life Sciences position peaked at $60.6M in Q4 2024.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Kynam Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.